THE GUT–BRAIN AXIS IN AUTISM SPECTRUM DISORDER: MICROBIOTA, IMMUNE DYSREGULATION, AND THERAPEUTIC PERSPECTIVES
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5176Keywords:
Autism Spectrum Disorder, Gut–Brain Axis, Gut Microbiota, Immune Dysregulation, Microbial Metabolites, Therapeutic InterventionsAbstract
Background: Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by persistent difficulties in social communication, restricted and repetitive behaviors, and a high prevalence of co-occurring gastrointestinal, metabolic, and immune disturbances. Increasing evidence suggests that the gut–brain axis—a bidirectional communication network linking intestinal microbiota, immune signaling, metabolic pathways, and neural circuits—may play an important modulatory role in ASD-related neurodevelopmental processes.
Scope: This review synthesizes current evidence on gut–brain axis physiology and examines how alterations in microbiota composition and function intersect with immune dysregulation, microbial metabolite signaling, and neurodevelopment in ASD. Findings from clinical studies, preclinical mechanistic research, and emerging microbiota-targeted therapeutic approaches are integrated to provide a systems-level perspective on microbiota–immune–brain interactions.
Key Findings: Individuals with ASD frequently exhibit altered gut microbial diversity and composition, accompanied by functional disruptions in microbial metabolite pathways, including short-chain fatty acid and tryptophan metabolism. These changes are associated with impaired intestinal barrier integrity, systemic immune activation, neuroinflammatory signaling, and microglial dysfunction, processes that may contribute to excitatory–inhibitory imbalance and altered synaptic plasticity in the central nervous system. Microbiota-targeted interventions—such as probiotics, dietary modification, and fecal microbiota transplantation—demonstrate preliminary benefits for gastrointestinal symptoms and selected behavioral outcomes, although clinical evidence remains heterogeneous and limited.
Conclusions: Current evidence supports a multifactorial model in which gut microbiota alterations act as modulatory amplifiers of neurodevelopmental vulnerability in ASD rather than as primary causal factors. Interactions among microbial metabolism, immune regulation, environmental exposures, and developmental timing appear central to this process. Future progress will depend on longitudinal, multi-omics approaches and biomarker-driven stratification to enable precision-based microbiota-targeted interventions.
References
Lord, C., Elsabbagh, M., Baird, G., & Veenstra-Vanderweele, J. (2018). Autism spectrum disorder. Lancet, 392(10146), 508–520. https://doi.org/10.1016/S0140-6736(18)31129-2
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Hultman, C., Larsson, H., & Reichenberg, A. (2017). The heritability of autism spectrum disorder. JAMA, 318(12), 1182–1184. https://doi.org/10.1001/jama.2017.121414
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., O'Connor, R., … Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.20185
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016). The central nervous system and the gut microbiome. Cell, 167(4), 915–932. https://doi.org/10.1016/j.cell.2016.10.027
McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: A meta-analysis. Pediatrics, 133(5), 872–883. https://doi.org/10.1542/peds.2013-3995
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism: Comparisons to typical children and correlation with autism severity. BMC Gastroenterology, 11, Article 22. https://doi.org/10.1186/1471-230X-11-22
Vuong, H. E., & Hsiao, E. Y. (2017). Emerging roles for the gut microbiome in autism spectrum disorder. Biological Psychiatry, 81(5), 411–423. https://doi.org/10.1016/j.biopsych.2016.08.024
Kang, D. W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., Pollard, E. L., Roux, S., Sadowsky, M. J., Lipson, K. S., Sullivan, M. B., Caporaso, J. G., & Krajmalnik-Brown, R. (2017). Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome, 5(1), Article 10. https://doi.org/10.1186/s40168-016-0225-7
Shtossel, O., Koren, O., Shai, I., Rinott, E., & Louzoun, Y. (2024). Gut microbiome-metabolome interactions predict host condition. Microbiome, 12(1), Article 24. https://doi.org/10.1186/s40168-023-01737-1
Mayer, E. A., Knight, R., Mazmanian, S. K., Cryan, J. F., & Tillisch, K. (2014). Gut microbes and the brain: Paradigm shift in neuroscience. The Journal of Neuroscience, 34(46), 15490–15496. https://doi.org/10.1523/JNEUROSCI.3299-14.2014
Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367209
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders. Frontiers in Psychiatry, 9, Article 44. https://doi.org/10.3389/fpsyt.2018.00044
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 16050–16055. https://doi.org/10.1073/pnas.1102999108
Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121–141. https://doi.org/10.1016/j.cell.2014.03.011
Estes, M. L., & McAllister, A. K. (2016). Maternal immune activation: Implications for neuropsychiatric disorders. Science, 353(6301), 772–777. https://doi.org/10.1126/science.aag3194
Hughes, H. K., Moreno, R. J., & Ashwood, P. (2023). Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain, Behavior, and Immunity, 108, 245–254. https://doi.org/10.1016/j.bbi.2022.12.001
Strandwitz, P. (2018). Neurotransmitter modulation by the gut microbiota. Brain Research, 1693(Pt B), 128–133. https://doi.org/10.1016/j.brainres.2018.03.015
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W. S., McCoy, K. D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., & Prinz, M. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 18(7), 965–977. https://doi.org/10.1038/nn.4030
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., Gulyás, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B. T., Diamond, B., & Pettersson, S. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine, 6(263), 263ra158. https://doi.org/10.1126/scitranslmed.3009759
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016). Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Molecular Autism, 7, Article 49. https://doi.org/10.1186/s13229-016-0110-z
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015). Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in Cellular Neuroscience, 9, Article 392. https://doi.org/10.3389/fncel.2015.00392
Strati, F., Cavalieri, D., Albanese, D., De Felice, C., Donati, C., Hayek, J., Jousson, O., Leoncini, S., Renzi, D., Calabrò, A., & De Filippo, C. (2017). New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome, 5(1), Article 24. https://doi.org/10.1186/s40168-017-0242-1
Parracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology, 54(Pt 10), 987–991. https://doi.org/10.1099/jmm.0.46101-0
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M. L., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., Collins, M. D., Lawson, P. A., Summanen, P., Baysallar, M., Tomzynski, T. J., Read, E., Johnson, E., Rolfe, R., Nasir, P., Shah, H., … Kaul, A. (2002). Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases, 35(Suppl 1), S6–S16. https://doi.org/10.1086/341914
Argou-Cardozo, I., & Zeidán-Chuliá, F. (2018). Clostridium bacteria and autism spectrum conditions: A systematic review and hypothetical contribution of environmental glyphosate levels. Medical Sciences, 6(2), Article 29. https://doi.org/10.3390/medsci6020029
Li, Q., Han, Y., Dy, A. B. C., & Hagerman, R. J. (2017). The gut microbiota and autism spectrum disorders. Frontiers in Cellular Neuroscience, 11, Article 120. https://doi.org/10.3389/fncel.2017.00120
De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013). Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLOS ONE, 8(10), Article e76993. https://doi.org/10.1371/journal.pone.0076993
Needham, B. D., Adame, M. D., Serena, G., Rose, D. R., Preston, G. M., Conrad, M. C., Campbell, A. S., Donabedian, D. H., Fasano, A., Ashwood, P., & Mazmanian, S. K. (2021). Plasma and fecal metabolite profiles in autism spectrum disorder. Biological Psychiatry, 89(5), 451–462. https://doi.org/10.1016/j.biopsych.2020.09.025
Kim, M., Vogtmann, E., Ahlquist, D. A., Devens, M. E., Kisiel, J. B., Taylor, W. R., White, B. A., Hale, V. L., Sung, J., Chia, N., Sinha, R., & Chen, J. (2020). Fecal metabolomic signatures in colorectal adenoma patients are associated with gut microbiota and early events of colorectal cancer pathogenesis. mBio, 11(1), Article e03186-19. https://doi.org/10.1128/mBio.03186-19
Madore, C., Leyrolle, Q., Lacabanne, C., Benmamar-Badel, A., Joffre, C., Nadjar, A., & Layé, S. (2016). Neuroinflammation in autism: Plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plasticity, 2016, Article 3597209. https://doi.org/10.1155/2016/3597209
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011). Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 25(1), 40–45. https://doi.org/10.1016/j.bbi.2010.08.003
Zhao, H., Zhang, H., Liu, S., Luo, W., Jiang, Y., & Gao, J. (2021). Association of peripheral blood levels of cytokines with autism spectrum disorder: A meta-analysis. Frontiers in Psychiatry, 12, Article 670200. https://doi.org/10.3389/fpsyt.2021.670200
Onore, C., Careaga, M., & Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity, 26(3), 383–392. https://doi.org/10.1016/j.bbi.2011.08.007
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57(1), 67–81. https://doi.org/10.1002/ana.20315
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews Gastroenterology & Hepatology, 16(8), 461–478. https://doi.org/10.1038/s41575-019-0157-3
Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23(6), 716–724. https://doi.org/10.1016/j.chom.2018.05.003
Gevi, F., Zolla, L., Gabriele, S., & Persico, A. M. (2016). Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Molecular Autism, 7, Article 47. https://doi.org/10.1186/s13229-016-0109-5
Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012). γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology, 113(2), 411–417. https://doi.org/10.1111/j.1365-2672.2012.05344.x
Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012). GABA system dysfunction in autism and related disorders: From synapse to symptoms. Neuroscience and Biobehavioral Reviews, 36(9), 2044–2055. https://doi.org/10.1016/j.neubiorev.2012.07.005
He, X., Liu, W., Tang, F., Chen, X., & Song, G. (2023). Effects of probiotics on autism spectrum disorder in children: A systematic review and meta-analysis of clinical trials. Nutrients, 15(6), Article 1415. https://doi.org/10.3390/nu15061415
Zhang, L., Xu, Y., Li, H., Li, B., Duan, G., & Zhu, C. (2022). The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial. PLOS ONE, 17(2), Article e0263109. https://doi.org/10.1371/journal.pone.0263109
Feng, P., Zhao, S., Zhang, Y., & Li, E. (2023). A review of probiotics in the treatment of autism spectrum disorders: Perspectives from the gut-brain axis. Frontiers in Microbiology, 14, Article 1123462. https://doi.org/10.3389/fmicb.2023.1123462
Hrnciarova, J., Kubelkova, K., Bostik, V., Rychlik, I., Karasova, D., Babak, V., Datkova, M., Simackova, K., & Macela, A. (2024). Modulation of gut microbiome and autism symptoms of ASD children supplemented with biological response modifier: A randomized, double-blinded, placebo-controlled pilot study. Nutrients, 16(13), Article 1988. https://doi.org/10.3390/nu16131988
Liu, J., Gao, Z., Liu, C., Liu, T., Gao, J., Cai, Y., & Fan, X. (2022). Alteration of gut microbiota: New strategy for treating autism spectrum disorder. Frontiers in Cell and Developmental Biology, 10, Article 792490. https://doi.org/10.3389/fcell.2022.792490
Marí-Bauset, S., Zazpe, I., Mari-Sanchis, A., Llopis-González, A., & Morales-Suárez-Varela, M. (2014). Evidence of the gluten-free and casein-free diet in autism spectrum disorders: A systematic review. Journal of Child Neurology, 29(12), 1718–1727. https://doi.org/10.1177/0883073814531330
Evangeliou, A., Vlachonikolis, I., Mihailidou, H., Spilioti, M., Skarpalezou, A., Makaronas, N., Prokopiou, A., Christodoulou, P., Liapi-Adamidou, G., Helidonis, E., Sbyrakis, S., & Smeitink, J. (2003). Application of a ketogenic diet in children with autistic behavior: Pilot study. Journal of Child Neurology, 18(2), 113–118. https://doi.org/10.1177/08830738030180020501
Garcia-Mantrana, I., Selma-Royo, M., Alcantara, C., & Collado, M. C. (2018). Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population. Frontiers in Microbiology, 9, Article 890. https://doi.org/10.3389/fmicb.2018.00890
Kang, D. W., Adams, J. B., Coleman, D. M., Pollard, E. L., Maldonado, J., McDonough-Means, S., Caporaso, J. G., & Krajmalnik-Brown, R. (2019). Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Scientific Reports, 9(1), Article 5821. https://doi.org/10.1038/s41598-019-42183-0
Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., Tang, W., Chen, L., Chen, M., Lv, L., Ping, Y., Chen, D., & Wei, Y. (2021). Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study. Frontiers in Cellular and Infection Microbiology, 11, Article 759435. https://doi.org/10.3389/fcimb.2021.759435
Fischbach, M. A. (2018). Microbiome: Focus on causation and mechanism. Cell, 174(4), 785–790. https://doi.org/10.1016/j.cell.2018.07.038
Lam, K. N., Alexander, M., & Turnbaugh, P. J. (2019). Precision medicine goes microscopic: Engineering the microbiome to improve drug outcomes. Cell Host & Microbe, 26(1), 22–34. https://doi.org/10.1016/j.chom.2019.06.011
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alia Echtay Yarbou, Rami Mallah, Dominika Julia Kozdroń, Michalina Weronika Nieścioruk, Dominika Raether, Adam Andrzejewski, Paulina Szczepańska, Jacek Kowalski, Dominika Dutkiewicz, Adrian Mikołajuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
